{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-031372","form_type":"8-K","ticker":"SER","cik":"0001708599","company_name":"Serina Therapeutics, Inc.","filed_at":"2022-11-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.787948+00:00","generated_at":"2026-06-21T23:12:13.915583+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"AgeX Therapeutics Q3 2022: Revenue $9K, cash $0.5M, substantial going concern doubt","bullets":["Cash and equivalents $0.5M; company says cash insufficient for next 12 months, raising substantial going concern doubt.","Total revenues $9,000 vs $24,000 prior-year quarter; R&D $0.2M, G&A $1.4M flat.","Borrowed additional $1.0M under $13.16M Secured Note from Juvenescence; $1.5M remaining, draws at Juvenescence's discretion.","$8M principal under earlier 2020 Loan Agreement due March 2023; Secured Note matures Feb 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-031372","json":"https://secwatch.observer/filing/0001493152-22-031372.json","markdown":"https://secwatch.observer/filing/0001493152-22-031372.md","text":"https://secwatch.observer/filing/0001493152-22-031372.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1708599/000149315222031372/0001493152-22-031372-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1708599/000149315222031372/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T23:12:13.915583+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"26416147665b4715f471a317e734de76852fdd46","claim":"Serina Therapeutics, Inc. reported financial results for the three months ended September 30, 2022.","evidence_excerpt":"On November 10, 2022, AgeX issued a press release announcing its financial results for the three months ended September 30, 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1708599/000149315222031372/0001493152-22-031372-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months ended September 30, 2022"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}